Dofetilide: a new class III antiarrhythmic for the management of atrial fibrillation.
Diaz
A L
AL
College of Pharmacy, Washington State University, USA.
Clifton
G D
GD
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000451:nursing; D004347:Drug Interactions; D006801:Humans; D010627:Phenethylamines / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D013449:Sulfonamides / Q000009:adverse effects*
D000889:Anti-Arrhythmia Agents; D010627:Phenethylamines; D013449:Sulfonamides; C063533:dofetilide